Table 2.
Asthma exacerbation in the public and private health systems.
| Public hospitals | Private hospitals | p | |
|---|---|---|---|
| Median days of hospital stay | 4 (3–6) | 3 (3–5) | <0.001 |
| Median days of PICU | 4 (2–5) | 4 (2–5) | 0.871 |
| Median days of oxygen | 3 (2–5) | 2 (2–4) | <0.001 |
| Median days of systemic corticosteroids | 4 (3–6) | 3 (3–5) | <0.001 |
| Number of patients receiving antibiotics | 127 (43.5%) | 32 (30.8%) | 0.027 |
| Number of patients receiving any of the second line medications (Aminophylline, Magnesium Sulfate or Ketamine) | 14 (4.8%) | 11 (10.6%) | 0.037 |
| Number of patients requiring NIV | 34 (11.6%) | 12 (11.5%) | 0.835 |
| Number of isolated virus | |||
| 0 | 266 (84.4%) | 49 (15.6%) | <0.0001* |
| 1 | 25 (33.8%) | 49 (66.2%) | |
| 2 | 1 (16.7%) | 5 (83.3%) | |
| 3 | 0 | 1 (100%) | |
| Number of patients with complications | 72 (24.7%) | 29 (27.9%) | 0.515 |
*
Kolmogorov test distribution equality.